Stay updated with breaking news from Development Headquarters. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
विरासत उचाइमा पु-याउँदै त्रिवि शेयर गर्नुहोस: सुमन्त घिमिरे त्रिभुवन विश्वविद्यालय मुलुककै सबैभन्दा जेठो विश्वविद्यालयमात्र नभएर, विद्यार्थी भर्नाका आधारमा विश्वकै १२औँ ठूलो विश्वविद्यालय पनि हो । यो हाम्र...
Regeneronâs COVID-19 drug authorized by FDA for injection By Stephanie Weaver Antibodies are Y-shaped proteins than bind to one's foreign invaders, like viruses, bacteria, fungi and parasites. WASHINGTON - The U.S. Food and Drug Administration has cleared a formulation of the COVID-19 antibody drug made by Regeneron Pharmaceuticals Inc. that can be injected, rather than administered by IV infusion, the company announced Friday. Regeneron’s monoclonal antibody drug, called REGEN-COV, has been available since last November under emergency-use authorization to treat mild-to-moderate COVID...
Regeneron said it now plans to request FDA clearance to use the COVID-19 antibody drug as a preventative treatment that could help provide immediate protection to unvaccinated people.
February 26, 2021 News Release Company name: ... | March 4, 2021
February 26, 2021 News Release Company name: ... | March 4, 2021